| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |